They found that the short-term survivors of PDAC patients (overall survival < 12 months) was negatively associated with patient age, tumor size of ≥3 cm based on a computerized tomography (CT) scan, and the level of serum carcinoembryonic antigen (CEA) [33]. This evidence concerns the gene CEACAM5 and neoplasm.